Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo

BACKGROUND: Despite the durable viral suppression afforded by antiretroviral therapy, HIV-1 eradication will require strategies to target latently infected cells that persist in infected individuals. Protein kinase C (PKC) activation is a promising strategy to reactivate latent proviruses and allow...

Descripción completa

Detalles Bibliográficos
Autores principales: Spivak, Adam M., Larragoite, Erin T., Coletti, McKenna L., Macedo, Amanda B., Martins, Laura J., Bosque, Alberto, Planelles, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175306/
https://www.ncbi.nlm.nih.gov/pubmed/27998278
http://dx.doi.org/10.1186/s12977-016-0319-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175306/
https://www.ncbi.nlm.nih.gov/pubmed/27998278
http://dx.doi.org/10.1186/s12977-016-0319-0

Ejemplares similares